Ditchcarbon
  • Contact
  1. Organizations
  2. Akeso Biopharma, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated a month ago

Akeso Biopharma, Inc. Sustainability Profile

Company website

Akeso Biopharma, Inc., a leading biopharmaceutical company headquartered in China, is at the forefront of innovative drug development. Founded in 2012, Akeso has rapidly established itself within the biotechnology industry, focusing on the research, development, and commercialisation of monoclonal antibodies and other biologics. With a strong presence in major operational regions across Asia and beyond, Akeso is renowned for its unique portfolio of core products, including innovative therapies for oncology and autoimmune diseases. The company has achieved significant milestones, including successful clinical trials and partnerships that enhance its market position. Akeso's commitment to advancing healthcare through cutting-edge biopharmaceutical solutions underscores its reputation as a key player in the global biopharma landscape.

DitchCarbon Score

How does Akeso Biopharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Akeso Biopharma, Inc.'s score of 20 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

Akeso Biopharma, Inc.'s reported carbon emissions

Akeso Biopharma, Inc., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As a result, Akeso Biopharma's climate commitments remain unclear, and there are no inherited emissions data from a parent or related organization. The lack of emissions reporting and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy.

How Carbon Intensive is Akeso Biopharma, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Akeso Biopharma, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Akeso Biopharma, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Akeso Biopharma, Inc. is in CN, which we do not have grid emissions data for.

Akeso Biopharma, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Akeso Biopharma, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Akeso Biopharma, Inc.'s Emissions with Industry Peers

Bio-Thera Solutions, Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy